What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Myocardial infarction
Leif Thuesen mainly investigates Surgery, Internal medicine, Myocardial infarction, Cardiology and Angioplasty.
The Surgery study combines topics in areas such as Coronary artery disease and Percutaneous coronary intervention.
His Internal medicine research is multidisciplinary, incorporating perspectives in Placebo and Endocrinology.
In general Myocardial infarction study, his work on Conventional PCI and Target lesion often relates to the realm of In patient, thereby connecting several areas of interest.
His research integrates issues of Stroke and Clinical trial in his study of Cardiology.
His study looks at the intersection of Angioplasty and topics like Revascularization with Paclitaxel, Major complication, Patient age, Percutaneous and Long term outcomes.
His most cited work include:
- A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction (1103 citations)
- BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS (797 citations)
- Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial (786 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Cardiology, Surgery, Myocardial infarction and Percutaneous coronary intervention.
His work in the fields of Conventional PCI, Hazard ratio and Sirolimus overlaps with other areas such as In patient.
His work carried out in the field of Cardiology brings together such families of science as Stroke and Coronary stent.
His biological study spans a wide range of topics, including Nuclear medicine and Cohort.
His studies deal with areas such as Thrombosis and Randomized controlled trial as well as Myocardial infarction.
His Stent study combines topics from a wide range of disciplines, such as Coronary artery disease and Mace.
He most often published in these fields:
- Internal medicine (63.08%)
- Cardiology (56.72%)
- Surgery (38.63%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (63.08%)
- Cardiology (56.72%)
- Surgery (38.63%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Cardiology, Surgery, Myocardial infarction and Percutaneous coronary intervention.
His work on Hazard ratio, Sirolimus and Stroke is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science.
His Cardiology research is multidisciplinary, incorporating elements of Restenosis and Coronary stent.
His research investigates the connection between Surgery and topics such as Clopidogrel that intersect with problems in Discontinuation.
The various areas that Leif Thuesen examines in his Myocardial infarction study include Thrombosis and Proportional hazards model.
His Percutaneous coronary intervention study also includes
- Coronary artery disease which is related to area like Cardiovascular agent,
- Angioplasty that intertwine with fields like Balloon.
Between 2011 and 2021, his most popular works were:
- Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction (404 citations)
- Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. (384 citations)
- Drug-Eluting vs Bare-Metal Stents in Primary Angioplasty: A Pooled Patient-Level Meta-analysis of Randomized Trials (209 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Myocardial infarction
His main research concerns Myocardial infarction, Surgery, Internal medicine, Cardiology and Percutaneous coronary intervention.
He combines subjects such as Restenosis and Hazard ratio with his study of Myocardial infarction.
The study incorporates disciplines such as Coronary artery disease, Stent thrombosis and Nuclear medicine in addition to Surgery.
Leif Thuesen works mostly in the field of Cardiology, limiting it down to topics relating to Stroke and, in certain cases, Relative risk.
The concepts of his Percutaneous coronary intervention study are interwoven with issues in ST segment, Angioplasty, Coronary occlusion and Intention-to-treat analysis.
His Angioplasty research is multidisciplinary, relying on both Framingham Risk Score and Balloon.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
